reglab/statecodes huggingface dataset:
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-3 - Definitions

Current through July 13, 2024
(a) "Collaborative pharmacy practice" is that
				practice of pharmacy whereby one or more pharmacists have jointly agreed, on a
				voluntary basis, to work in conjunction with one or more practitioners in
				collaboration to provide patient care services to achieve optimal medication
				use and desired patient outcomes.
(b) "Collaborative practice agreement" is a
				written and signed agreement between one or more pharmacists and one or more
				practitioners that defines a collaborative practice.
(c) "Compounding" means the preparation,
				mixing, assembling, altering, packaging, or labeling of a drug, drug-delivery
				device, or device, unless performed in a Food and Drug Administration
				(FDA)-registered outsourcing facility in conformance with Federal law, in
				accordance with a licensed practitioner's prescription, medication order, or
				initiative based on the practitioner/patient/pharmacist/compounder relationship
				in the course of professional practice. Compounding includes the following:
(i) Preparation of drug dosage forms for both
				human and animal patients;
(ii)
				Preparation of drugs or devices in anticipation of prescription drug orders
				based on routine, regularly observed prescribing patterns; and
(iii) Manipulation of commercial products for
				patient-specific needs beyond FDA-approved labeling.
(iv) Compounding does not include mixing,
				reconstituting, adding flavoring or other such acts that are performed in
				accordance with directions contained in approved labeling provided by the
				product's manufacturer and other manufacturer directions consistent with the
				labeling.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-4 - Responsibilities of the Pharmacist-in-Charge (PIC)

Current through July 13, 2024
(a) Every resident pharmacy shall designate
				one pharmacist, who is licensed by the Board, as the PIC.
(b) Every non-resident pharmacy shall
				designate one registered pharmacist as the PIC.
(c) A pharmacist may not serve as PIC for
				more than one pharmacy at a time unless the pharmacist obtains a waiver from
				the Board.
(d) A PIC shall:
(i) Direct the pharmacy's operations and
				staff;
(ii) Ensure all pharmacy and
				professional staff licenses are current and on display;
(iii) Ensure all expired or recalled drug
				products are removed from active stock and placed in a designated quarantine
				area for return or destruction;
(iv) Ensure the proper management of drug
				recalls which may include, where appropriate, contacting patients to whom the
				recalled drug product(s) have been dispensed; and
(v) Maintain all pharmacy records required by
				state and federal law in a readily retrievable format.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-5 - Responsibilities of the Pharmacy License Holder

Current through July 13, 2024
(a) The pharmacy license holder shall:
(i) Designate a PIC;
(ii) Notify the Board upon notice of the
				vacancy of the PIC for a period exceeding thirty (30) days.
(iii) Ensure the pharmacy operates in
				compliance with all state and federal laws, rules and regulations.
(iv) Ensure the pharmacy has at least one
				physically present licensed pharmacist on duty at all times the pharmacy is
				open;
(v) Ensure a sign stating
				"Pharmacy Closed - No Pharmacist on Duty" is conspicuously posted when there is
				no pharmacist present in the building;
(vi) Ensure a working environment is provided
				to staff that protects the health, safety and welfare of patients, which
				includes, but is not limited to:
(A)
				Sufficient staffing with pharmacists, pharmacy interns, pharmacy technicians,
				and/or pharmacy technicians in training as may be required to competently and
				safely provide pharmacy services.
(B) Appropriate opportunities for meal
				breaks.
(vii) Notify the
				Board of any of the following:
(A) Change in
				ownership of the pharmacy;
(B)
				Change in address of the pharmacy;
(C) Permanent closing of the
				pharmacy;
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-6 - Requirements for issuing valid prescriptions

Current through July 13, 2024
(a) In order for a prescription drug to be
				valid it must be issued for a legitimate medical purpose by a practitioner
				acting in the usual course of his or her professional practice. The
				responsibility for the proper prescribing of the prescription drug is upon the
				prescribing practitioner, but a corresponding responsibility rests with the
				pharmacist who dispenses the prescription.
(b) All non-controlled substance
				prescriptions and refill authorizations shall contain the following:
(i) The patient's full name and date of
				birth;
(ii) Name and strength of
				the drug;
(iii) Quantity to be
				dispensed, including refills, if applicable;
(iv) Directions for use;
(v) Date issued by the
				practitioner;
(vi) The
				practitioner's full name, address, telephone number; and
(vii) If a written or faxed prescription, the
				recognizable signature of the issuing practitioner; or
(viii) If an electronically transmitted
				prescription, the prescribing practitioner's electronic or digital signature;
				or
(ix) If a verbal order, the name
				of the authorized agent providing information, if other than
				prescriber.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-7 - Personal Responsibility and Accountability

Current through July 13, 2024
(a) Each pharmacist, pharmacy intern,
				pharmacy technician, and pharmacy technician in training shall be responsible
				and accountable for their own actions performed in their practice of
				pharmacy.
(b) If any action of the
				supervising pharmacist is deemed to contribute to or cause a violation of the
				Wyoming Pharmacy Act, the Wyoming Controlled Substances Act, or the Board's
				Rules and Regulations, the supervising pharmacist may be held
				responsible.
(c) If any action of
				the pharmacy license holder is deemed to contribute to or cause a violation of
				the Wyoming Pharmacy Act, the Wyoming Controlled Substances Act, or the Board's
				Rules and Regulations, the pharmacy license holder may be held
				responsible.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-8 - Unprofessional Conduct

Current through July 13, 2024
(a) It shall be unprofessional conduct for
				any licensed pharmacy staff member to practice pharmacy while under the
				influence of alcohol or drugs.
(b)
				It shall be unprofessional conduct for any licensed pharmacy staff member in
				the pharmacy to practice pharmacy with a mental or physical impairment
				affecting his or her ability to safely and competently practice
				pharmacy.
(c) It shall be
				unprofessional conduct for any licensed pharmacy staff member to sexually
				harass another licensee, employee of the pharmacy, or patient.
(d) It shall be unprofessional conduct for
				any licensed pharmacy staff member to not report another pharmacy staff member
				suspected of engaging in unprofessional conduct to the Board.
(e) It shall be unprofessional conduct for a
				licensed pharmacy or licensed pharmacy staff member to distribute or dispense
				prescription drug samples.
(f) It
				shall be unprofessional conduct for a resident or non-resident pharmacy, or
				pharmacist, to dispense, sell or offer to sell prescription drugs to persons on
				the basis of a prescription generated solely through an internet practitioner
				consultation questionnaire. All pharmacies or pharmacists included in this
				section are prohibited from linking an internet site with or relating a site,
				to any other site, business or practitioner that provides prescriptions for
				medications solely on the basis on an internet practitioner consultation
				questionnaire.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-9 - Refill Authorization

Current through July 13, 2024
(a) If a refill was not authorized on the
				original prescription or, if no refills remain, pharmacy staff may contact the
				prescriber to obtain refill authorization or a new prescription at the request
				of a patient.
(b) When refill
				authorization is obtained, the name of the practitioner authorizing the
				prescription and, if applicable, the name of the agent transmitting the
				prescription, must be recorded, as well as the number of refills
				authorized.
(c) The following
				information shall be recorded in a readily retrievable manner when a
				prescription is refilled:
(i) Date
				refilled;
(ii) Quantity;
				and
(iii) Pharmacy staff's initials
				who are involved in dispensing the refill.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-10 - Labeling Prescription Drug Containers

Current through July 13, 2024
(a) All original or refill prescription drug
				containers dispensed by a pharmacy shall be labeled with the following:
(i) The patient's full name; or
(ii) If the patient is an animal, the
				animal's name, species and the owner's last name;
(iii) Brand or generic name of the drug
				product dispensed, unless otherwise specified;
(iv) Drug strength and quantity;
(v) Directions for use;
(vi) The name, address, and telephone number
				of the pharmacy;
(vii) The
				practitioner's name;
(viii) The
				serialized number of the prescription;
(ix) The date the prescription was filled or
				refilled;
(x) The product's
				physical description, including any identification code that may appear on the
				tablets and capsules, and;
(xi)
				Purpose for use where appropriate
(xii) Accessory cautionary labels for patient
				safety, where appropriate.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-11 - Patient Records

Current through July 13, 2024
(a) A patient profile record shall be
				maintained by pharmacies for patients for whom prescriptions are
				dispensed.
(b) The profile record
				shall provide for the immediate retrieval of information of previously
				dispensed drugs and devices.
(c)
				The pharmacy software shall be able to maintain the following patient
				information for each new prescription:
(i)
				Patient's full name;
(ii) Patient's
				address and telephone number;
(iii)
				Patient's date of birth;
(iv)
				Patient's sex; and
(v) A list of
				all prescription drug orders obtained at the pharmacy during the two years
				immediately preceding the most recent entry showing the name of the drug or
				device, prescription number, strength of the drug, quantity, date received and
				the name of the prescriber;
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-12 - Transfer of Non-Controlled Substance Prescription Orders Between Pharmacies

Current through July 13, 2024
(a) A pharmacy shall transfer prescription
				order information for non-controlled substances upon the request of the
				patient.
(b) Transfer of
				prescription order information for the purpose of filling or refilling a
				prescription is subject to the following requirements:
(i) A prescription order for a non-controlled
				prescription drug may be transferred from one pharmacy to another pharmacy only
				so long as there are refills remaining.
(ii) Both the original and transferred
				prescription drug orders shall be maintained and readily retrievable for a
				period of two years from the date of last refill at the respective
				pharmacy;
(iii) Pharmacies
				electronically transferring information must satisfy all information
				requirements of a transferred prescription including those requirements in W.S.
				§
										33-24-136;
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-13 - Return of Unused Prescription Drugs

Current through July 13, 2024
(a) A pharmacist may:
(i) Accept and redistribute an unused
				prescription drug under the Wyoming Drug Donation Program Act, W.S. §
										35-7-1601 et seq or its rules;
				or
(ii) Accept and redistribute any
				unused prescription drug, or a part of it, after it has left the premises of
				the pharmacy if:
(A) The drug was intended for
				inpatients of an institutional facility and has been maintained in the custody
				and control of the institutional facility or dispensing pharmacy;
(B) The drug was returned to the original
				dispensing pharmacy;
(C) The drug
				is in a single unit dose or unit of use package or in the manufacturer's sealed
				container;
(D) In the professional
				judgment of the PIC of the pharmacy, the safety and efficacy of the drug has
				not been compromised during transportation and storage;
(E) A system is in place to track the
				restocked drug for purposes of a recall; and
(F) Accepting and redistributing of the drug
				complies with state and federal law.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-14 - Therapeutic Equivalents

Current through July 13, 2024
(a) Therapeutic equivalents do not include
				therapeutic substitutions. Therapeutically equivalent is defined in W.S. §
									33-24-147(a)(v).
				Therapeutic substitution is that class of drug having the same or similar
				action, but not the identical composition.
(b) Pharmaceuticals that are considered to be
				therapeutic substitution instead of generic substitution shall not be used by
				retail/non-resident pharmacies. An institutional pharmacy using a formulary may
				reach a written agreement with members of the medical staff under which
				therapeutic substitution is permitted for use of formulary drugs.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-15 - Shared Pharmacy Services

Current through July 13, 2024
(a) Minimum requirements for shared pharmacy
				services:
(i) A resident or a non-resident
				pharmacy may participate in shared pharmacy services by another licensed
				pharmacy or pharmacist, provided involved parties:
(A) Have entered into a written agreement,
				specifying the services to be provided and the responsibilities and
				accountabilities of each party, or are of common ownership;
(B) Have a system in place to identify the
				parties responsible for each aspect of prescription preparation.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-16 - Collaborative Pharmacy Practice

Current through July 13, 2024
(a) Collaborative pharmacy practice is where
				one (1) or more pharmacists jointly agree to work under a protocol authorized
				by one (1) or more prescribers to provide patient care and drug therapy
				management services not otherwise permitted to be performed by a pharmacist
				under specified conditions.
(b) A
				collaborative practice agreement must be in place prior to engaging in
				collaborative pharmacy practice.
(c) The collaborative practice agreement must
				explain the scope of the pharmacist's practices and shall be updated upon any
				changes in the scope or agreement of practices.
(d) A copy of the signed agreement and any
				additional information regarding the agreement must be readily retrievable upon
				request by the Board.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-17 - Medication Therapy Management

Current through July 13, 2024
Medication Therapy Management (MTM) services may be performed
				  without a collaborative practice agreement. These services may include, but are
				  not limited to:
(a) Such other patient
				care services as may be allowed by law;
(b) Ordering, or performing laboratory
				assessments; and
(c) Evaluating the
				response of the patient to therapy, as it directly relates to MTM, provided:
(i) The pharmacy or service is certified by
				the US Department of Health and Human Services, as a clinical laboratory under
				the Clinical Laboratory Improvement Amendments (CLIA); or
(ii) The tests do not otherwise require a
				physician's order and the pharmacy or service has obtained a CLIA Certificate
				of Waiver from the US Department of Health and Human Services; and
(iii) The pharmacist is qualified to direct
				the laboratory.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 2 - GENERAL PRACTICE OF PHARMACY REGULATIONS › Section 2-18 - Ancillary Drug Supply for Nursing Homes, Hospices, Extended Care Facilities or Intermediate Care Facilities

Current through July 13, 2024
(a) Nursing homes, hospices, extended care
				facilities, or intermediate care facilities licensed by the Wyoming Department
				of Health may be issued a permit by the Board to maintain an ancillary supply
				of drugs, both scheduled and non-scheduled subject to approval by the Board.
				The drugs maintained in the ancillary drug supply shall remain the property of
				the pharmacy to which the permit was jointly issued.
(i) The pharmacy servicing the facility or
				facilities listed in this chapter shall make application to the Board, on an
				application form provided by the Board. The Board may issue a permit, if the
				conditions of this section are met, in the name of the facility and the
				pharmacy authorizing the storage and use of an ancillary drug supply at the
				facility. This registration shall be valid until June 30 of each year. The
				permit must be renewed annually.
(ii) The permit may be revoked by the Board,
				if conditions as outlined in this Section are not followed, or for other
				violations of the Wyoming Pharmacy Act or Wyoming Controlled Substances Act or
				Rules promulgated under said Acts.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-2 - Interns in Pharmacy

Current through July 13, 2024
(a) "Intern" means any person who:
(i) Has entered the first professional year
				in an approved college or school of pharmacy, who is in good standing with the
				approved college or school of pharmacy, and who has duly registered with the
				Board; or
(ii) Those applicants who
				are graduates of an approved college or school of pharmacy seeking licensure by
				examination or score transfer who:
(A) lack
				the required amount of practical experience for licensure, and who have duly
				registered with the Board; or
(B)
				are awaiting examination for licensure
(iii) Those applicants for reciprocity who
				have not been in active practice and must complete an internship, and who have
				duly registered with the Board; or
(iv) Those applicants for reinstatement of a
				lapsed license who must complete a required amount of practical experience, and
				who have duly registered with the Board; or
(v) Those applicants for licensure who are
				considered foreign pharmacy graduates and possess a Foreign Graduate
				Examination CommitteeT (FPGEC®) Certificate who
				must complete one thousand two hundred (1,200) hours of practical experience
				for licensure, and who have duly registered with the Board,
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-2 - Definitions

Current through July 13, 2024
(a) "ACPE" means Accreditation Council for
				Pharmacy Education its agent, designee or successor.
(b) "FPGEC" means Foreign Pharmacy Graduate
				Examination Committee or its successor.
(c) "Pharmacy intern" means a person who is
				registered with the Board as a pharmacy intern.
(d) "Preceptor" means a pharmacist or other
				health care professional licensed and in good standing with their respective
				Boards who supervises the internship training of a pharmacy intern.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-3 - Internship Training Requirements

Current through July 13, 2024
(a) The practical experience requirement for
				licensure as a pharmacist in Wyoming by examination or score transfer shall be
				met by the successful completion of a clinical clerkship program during a
				student's tenure at an approved college of pharmacy, provided the clinical
				clerkship consists of a minimum of one thousand two hundred (1,200) hours of
				practical experience.
(b) The Board
				shall annually review and approve the clinical clerkship program offered by the
				University of Wyoming, School of Pharmacy.
(c) Experience obtained in another state
				shall be accepted only if the regulatory agency in the state where the
				experience is obtained provides satisfactory proof of such experience or the
				approved college or school of pharmacy provides satisfactory proof of
				successful completion of a clinical clerkship program during the student's
				tenure at the approved college or school of pharmacy and provides the total
				hours of practical experience gained.
(d) The Board may approve up to five hundred
				(500) hours of practical experience for periods of non-traditional internships.
				A non-traditional internship is any period of experience other than experience
				gained in a traditional retail or hospital pharmacy setting. Interns
				participating in non-traditional internships under this subsection;
(i) May request prior review of the
				experience by the Board;
(ii) Shall
				be supervised by a licensed pharmacist if no preceptor pharmacist is available;
				and
(iii) Shall adhere to all
				requirements of this chapter including, but not limited to, proper reporting to
				the Board on Board-approved forms.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-3 - Qualifications for Pharmacy Interns

Current through July 13, 2024
(a) Submit a completed application on a form
				furnished by the Board, including payment of all fees;
(b) Complete a background check through the
				Wyoming Division of Criminal Investigation (DCI);
(c) Have no history of drug abuse or provide
				satisfactory evidence of rehabilitation; and
(i) Be enrolled and in good standing with an
				ACPE accredited school or college of pharmacy; or
(ii) Be a graduate from an ACPE accredited
				school or college of pharmacy; or
(iii) Be a graduate from a foreign school or
				college of pharmacy who has established education equivalency by obtaining a
				FPGEC Certification and who is currently licensed by the Board for the purpose
				of obtaining practical experience as a requirement for licensure as a
				pharmacist; or
(iv) An applicant
				awaiting licensure as a pharmacist by reciprocity who cannot provide proof of
				active practice and must complete an internship in Wyoming approved by the
				Board of no less than four hundred (400) hours; or
(v) An applicant for reinstatement of their
				pharmacist license after failure to renew or retuning from inactive status who
				must demonstrate minimum competency by completing an internship in Wyoming
				approved by the Board. The internship period may vary depending upon how long
				the individual was out of practice.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-4 - Intern Training

Current through July 13, 2024
(a) Interns shall, under the direct
				supervision of the preceptor pharmacist or academic preceptor:
(i) Fill prescriptions, including I.V.
				orders, and comment on any unusual prescription. Interns shall evaluate
				prescriptions as to drug, dose, and therapeutic effect. This evaluation may be
				submitted in written form or discussed orally with the preceptor
				pharmacist.
(ii) Be instructed in
				the proper handling of controlled substances and all other drugs requiring
				special attention, including over-the-counter products.
(iii) Gain familiarity with brand names,
				generic names, and dosage forms.
(iv) Become familiar with the proper handling
				of veterinarian products, if pertinent to the practice setting.
(v) Be supervised in the appropriate
				counseling of patients regarding self-administration of drugs.
(vi) Make the offer to counsel and provide
				appropriate counseling to patients regarding self administration of
				prescription drugs and over-the-counter drug products.
(vii) Accept verbal medication orders from a
				prescribing practitioner.
(viii)
				Transfer prescriptions, as provided in chapter 2.
(ix) Conduct prospective and retrospective
				drug utilization reviews, including the identification of problems and steps
				required to resolve identified problems.
(x) Become familiar with medication therapy
				management, including communicating with health care providers and patients
				regarding medication management.
(xi) Become familiar with pharmacy
				record-keeping requirements.
(xii)
				Provide pharmaceutical care.
(xiii)
				Compound non-sterile and sterile medications.
(xiv) Administer immunizations under the
				supervision of a pharmacist who is licensed by the Board.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-4 - Pharmacy Intern Registration; Fees; Licenses

Current through July 13, 2024
(a) The Board reserves the right to require
				an interview of the applicant prior to a pharmacy intern license being
				issued.
(b) Pharmacy intern
				licenses shall expire annually on September 30.
(c) A pharmacy intern shall not practice in
				this state with an expired license.
(d) A pharmacy intern license shall not be
				renewed beyond twenty-four (24) months from the date of graduation from an ACPE
				accredited school or college of pharmacy where the initial degree in pharmacy
				is obtained.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-5 - Preceptor Pharmacist Rules

Current through July 13, 2024
(a) Definitions of preceptors are as follows:
(i) "Academic preceptor" means a pharmacist
				who is supervising the training of pharmacy interns provided through an
				approved academic program and not necessarily licensed as a pharmacist in
				Wyoming.
(ii) "Preceptor
				pharmacist" means a pharmacist who is supervising pharmacy interns that are
				employed by the pharmacy, or are obtaining intern hours outside of a formal
				academic rotation.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 3 - PHARMACY INTERNSHIP REGULATIONS › Section 3-5 - Pharmacy Internship Requirements

Current through July 13, 2024
(a) Graduates of an ACPE accredited school or
				college of pharmacy shall complete one thousand two hundred (1,200) hours of
				practical pharmacy experience.
(b)
				The Board shall annually review and approve the practical pharmacy experience
				program offered by the University of Wyoming, School of Pharmacy.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 4 - CODE OF ETHICS › Section 4-2 - Code of Ethics

Current through July 13, 2024
(a) A pharmacist
				has the duty to observe the law, uphold the dignity and honor of the profession
				and to accept its ethical principles.
(b) A pharmacist shall hold the health and
				safety of patients to be of first consideration.
(c) A pharmacist shall not condone the
				dispensing, promoting or distributing of drugs or medical devices which do not
				meet standards required by law or which lack therapeutic value for the
				patient.
(d) A pharmacist shall
				strive to improve and enlarge professional knowledge and shall utilize that
				knowledge in accordance with professional judgment.
(e) It shall be considered unprofessional
				conduct for a pharmacist to deliver a prescription drug without having a valid
				drug order as described in chapter 2 from a practitioner authorized by law to
				prescribe.
(f) Pharmacists shall
				not participate in transactions with any person under which fees are divided or
				may cause financial or other exploitation in connection with the rendering of
				professional services.
(g) A
				pharmacist shall respect the confidential and personal nature of patient
				records and shall not disclose the information without proper patient
				authorization except when required by law. In an emergency medical situation,
				the patient's records may be released to another pharmacist or other medical
				personnel involved in treating the patient.
(h) A pharmacist shall not provide
				practitioners with pre-printed prescription blanks bearing the pharmacy or
				pharmacist name or address.
(i) Any
				behavior by a pharmacist toward a patient, another licensee, or an employee of
				a pharmacy that exploits the position of trust, knowledge, emotions or
				influence of the licensee or any behavior by a pharmacist which involves offers
				to exchange pharmacy services for some form of sexual gratification shall be
				considered unprofessional conduct
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 6 - CONTINUING PROFESSIONAL EDUCATION REGULATIONS › Section 6-2 - Definitions

Current through July 13, 2024
"Previous License Period" means the calendar year (January 1
				  through December 31) immediately preceding the year for which the pharmacist is
				  seeking a license renewal.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 6 - CONTINUING PROFESSIONAL EDUCATION REGULATIONS › Section 6-3 - Continuing Pharmaceutical Education (CPE) Requirement for Pharmacists

Current through July 13, 2024
(a) In accordance with W.S. §
									33-24-121, all pharmacists must
				complete and report fifteen (15) hours of approved continuing pharmaceutical
				education (CPE) obtained during the previous license period in order to renew
				their license to practice pharmacy.
(b) Pharmacists are exempt from the CPE
				requirement for their first license renewal period.
(c) At least one and one-half (1.5) of the
				fifteen (15) hours of CPE obtained in a licensing period must be related to the
				responsible prescribing of controlled substances, pursuant to W.S. §
									33-24-121(d),
				which may include courses on pain management/opioids.
(d) At least one (1) hour of CPE must be
				related to immunizations for pharmacists who indicate they intend to administer
				immunizations on their license renewal application.
(e) Pharmacists must complete CPE programs
				approved by the Accreditation Council for Pharmacy Education (ACPE);
(f) Pharmacists are required to obtain the
				required CPE and have it reported into NABP's CPE monitor in order to renew
				their license. If audited, failure to demonstrate evidence of completing the
				required CPE constitutes prima facie evidence of knowingly submitting false or
				misleading information to the Board for the renewal of a license and may
				subject the pharmacist to disciplinary action by the Board.
(g) CPE credits shall not be carried forward
				to subsequent years.
(h) A
				pharmacist who is not engaged in the practice of pharmacy in Wyoming may
				request inactive license status on their renewal application, and is exempt
				from the CPE requirements for the license period(s) while remaining
				inactive.
(i) A pharmacist who is
				on inactive status may be reactivated upon completing the CPE requirements for
				each year of inactive status, not to exceed five (5) years.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 6 - CONTINUING PROFESSIONAL EDUCATION REGULATIONS › Section 6-4 - Continuing Pharmaceutical Education (CPE) Requirement for Registered Pharmacy Technicians

Current through July 13, 2024
(a) All registered pharmacy technicians must
				complete and report ten (10) hours of approved CPE obtained during the previous
				license period in order to renew their license to practice pharmacy.
(b) Registered pharmacy technicians are
				exempt from the CPE requirement for their first license renewal
				period.
(c) For registered pharmacy
				technicians who have indicated they provide immunizations on their renewal
				application, at least one (1) hour of CPE obtained in the previous licensing
				period must be related to immunizations.
(d) Registered pharmacy technicians must
				complete CPE programs approved by ACPE.
(e) Registered pharmacy technicians are
				required to obtain the required CPE and have it reported into NABP's CPE
				monitor. If audited, failure to demonstrate evidence of completing required CPE
				constitutes prima facie evidence of knowingly submitting false or misleading
				information to the Board for the renewal of a license and may subject the
				registered pharmacy technician to disciplinary action by the Board.
(f) CPE hours shall not be carried forward to
				the subsequent years.
(g) A
				registered pharmacy technician who is not engaged in the practice of pharmacy
				in Wyoming may request inactive license status on their renewal application,
				and is exempt from the CPE requirements for the license period(s) while
				remaining inactive.
(h) A
				registered pharmacy technician who is on inactive status may be reactivated
				upon completing the CPE requirements for each year of inactive status, not to
				exceed five (5) years.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-2 - Purpose

Current through July 13, 2024
The purpose of this rule is to provide for the minimum
				  licensing standards necessary to ensure the safety and efficacy of prescription
				  drugs offered for sale by manufacturers and wholesale
				  distributors.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-4 - Definitions

Current through July 13, 2024
(a) "Authorized Distributor of Record" means
				a wholesale distributor with whom a manufacturer has established an ongoing
				relationship to distribute the manufacturer's products.
(b) "Common Carrier" means any person or
				entity who undertakes directly or indirectly to transport property, including
				prescription drugs, for compensation.
(c) "Designated Representative" means an
				individual designated by the wholesale distributor and who is actively involved
				in and aware of the actual daily operation of the wholesale drug distributor at
				the wholesaler's licensed location.
(d) "Dispenser" means a retail pharmacy,
				institutional pharmacy, a group of chain pharmacies under common ownership and
				control that do not act as a wholesale distributor, or any other person
				authorized by law to dispense or administer prescription drugs, and the
				affiliate warehouses or distribution centers of such entities under common
				ownership and control that do not act as a wholesale distributor; and does not
				include a person who dispenses only products to be used in animals.
(e) "Distribute" or "Distribution" means the
				sale, purchase, trade, delivery, handling, storage, or receipt of a product,
				and does not include the dispensing of a product pursuant to a
				prescription.
(f) "Drug" means a
				substance recognized as a drug in any official compendium as listed in W.S.
				§
									
										33-24-127, designated for use in the
				diagnosis, cure, mitigation, treatment or prevention of disease in humans or
				animals.
(g) "Drug Sample" means a
				unit of a prescription drug that is not intended to be sold but is intended to
				promote the sale of the drug.
(h)
				"Food and Drug Administration" (FDA) means a federal agency within the United
				States Department of Health.
(i)
				"Illegitimate product" means a product for which credible evidence shows that
				the product:
(i) Is counterfeit, diverted or
				stolen;
(ii) Is intentionally
				adulterated such that the product would result in serious adverse health
				consequences or death to humans;
(iii) Is the subject of a fraudulent
				transaction; or
(iv) Appears
				otherwise unfit for distribution such that the product would be reasonably
				likely to result in serious adverse health consequences or death to
				humans.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-6 - Medical Oxygen Distributors

Current through July 13, 2024
(a) Medical oxygen is a prescription drug and
				distributors or manufacturers or repackagers shall be licensed by the Board and
				annually renew their licensure in order to provide medical oxygen in or into
				this State.
(b) Medical oxygen
				distributors located in this state may be inspected by the Board.
(c) Medical oxygen distributors shall
				complete all the requirements in this Chapter with the exception that they do
				not need VAWD® accreditation.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-7 - Outsourcing Facilities

Current through July 13, 2024
(a) Outsourcing facilities shall be licensed
				by the FDA under section 503(b).
(b) Resident and non-resident outsourcing
				facilities shall be licensed as such in this State and annually renew their
				licensure.
(c) Outsourcing
				facilities located in this State shall be inspected by the Board.
(d) Outsourcing facilities shall complete all
				the requirements in this Chapter with the exception that they do not need
				VAWD® accreditation.
(e) Outsourcing facilities shall:
(i) Compound drugs by or under the direct
				supervision of a licensed pharmacist;
(ii) Compound drugs in accordance with
				current good manufacturing practice (cGMP) as required by federal
				law;
(iii) Ensure that pharmacists
				conducting or supervising compounding shall be proficient in the art of
				compounding and shall acquire the education, training, or experience to
				maintain that proficiency and become certified by a compounding certification
				program approved by the Board;
(iv)
				Label compounded drugs with:
(A) Required drug
				and ingredient information;
(B)
				Facility identification;
(C) The
				following or similar statement: "This is a compounded drug. For office use
				only" or "Not for resale;" and
(v) Only compound using bulk drug substances
				that meet specified FDA criteria. May also compound drugs that appear on an FDA
				shortage list if the bulk drug substances used comply with the aforementioned
				specified criteria.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-8 - Third Party Logistics Providers

Current through July 13, 2024
(a) Third Party Logistics Providers (3PL)
				shall be licensed as such in this State and annually renew their
				licensure.
(b) Third Party
				Logistics Providers shall complete all the requirements in this
				Chapter.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-9 - Wholesale Distributors of Prescription Drugs for Non-Human Use

Current through July 13, 2024
(a) Veterinary prescription drug wholesale
				distributors may be licensed as such in this State and annually renew their
				license.
(b) Veterinary
				prescription drug wholesale distributors located in this State may be inspected
				by the Board.
(c) Veterinary
				prescription drug wholesale distributors applying for or renewing a license in
				this State shall complete all the requirements of this Chapter with the
				exception that they do not need VAWD®
				accreditation and they are not required to provide a designated
				representative.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-10 - Repackagers

Current through July 13, 2024
(a) Repackagers of prescription drugs for
				human use shall be licensed as such in this State and annually renew their
				licensure.
(b) Repackagers shall
				complete all the requirements in this Chapter.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-11 - Minimum Qualifications

Current through July 13, 2024
(a) The Board shall consider the following
				factors in determining eligibility for, and renewal of, licensure:
(i) Any criminal convictions, except minor
				traffic violations, or civil penalties of the applicant under any federal,
				state or local laws;
(ii) Any
				findings by the Board that the applicant has violated, or been disciplined by a
				regulatory agency in any state for violating any federal, state or local
				laws;
(iii) The furnishing by the
				applicant of false or fraudulent material in any application;
(iv) Suspension, sanction, or revocation by
				federal, state or local government against any license currently or previously
				held by the applicant or any of its owners for violations of state or federal
				laws regarding prescription drugs;
(v) Compliance with the requirements to
				maintain or make available to the Board or to federal, state or local law
				enforcement officials any required records; and
(vi) Any other factors or qualifications the
				Board considers relevant to and consistent with public health and
				safety.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-12 - Personnel

Current through July 13, 2024
(a) Each person that is issued an initial or
				renewal license as a manufacturer, repackager, third party logistics provider
				or wholesale distributor of prescription drugs for human use, whether in state
				or out of state, must designate in writing on a form required by the Board, a
				person for each facility to serve as the designated representative.
(b) To be certified as a designated
				representative, a person shall:
(i) Submit an
				application on a form furnished by the Board and provide information that
				includes:
(A) Fingerprint cards and fee for a
				criminal background check;
(B) Date
				and place of birth;
(C)
				Occupations, positions of employment, and offices held during the past seven
				(7) years;
(D) Principal business
				and address of any business corporation, or other organization in which each
				such office of the person was held or in which each such occupation or position
				of employment was carried on;
(E)
				Whether the person, during the past seven (7) years, has been enjoined, either
				temporarily or permanently, by a court of competent jurisdiction for violating
				any federal or state law regulating the possession, control or wholesale
				distribution of prescription drugs, together with details of such
				events;
(F) A description of any
				involvement by the person with any business, including any investments, other
				than the ownership of stock in a publicly traded company or mutual fund, during
				the past seven (7) years, which manufactured, administered, prescribed,
				wholesale distributed, or stored prescription drugs in which such businesses
				were named as a party in a lawsuit;
(G) A description of any felony criminal
				offense, or any offense (misdemeanor or felony) involving moral turpitude, or
				any offense related to the qualifications, functions or duties of that person
				in connection with the operation of the entity, of which the person, as an
				adult, was found guilty, regardless of whether adjudication of guilty was
				withheld or whether the person pled guilty or nolo contendere. If the person
				indicates that a criminal conviction is under appeal and submits a copy of the
				notice of appeal of the criminal offense, the applicant must, within thirty
				(30) days after the disposition of the appeal, submit a copy of the final
				written order of disposition to the Board; and
(H) A passport type and size of photograph of
				the person taken within the previous year.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-13 - General Minimum Requirements of Facilities Storing and Handling Prescription Drugs

Current through July 13, 2024
The following are required for the storage, handling,
				  transport and shipment of prescription drugs and for the establishment and
				  maintenance of records:
(a) All
				facilities at which prescription drugs are received, stored, warehoused,
				handled, held, offered, marketed, transported from or displayed shall:
(i) Be of suitable size and construction to
				facilitate cleaning, maintenance and proper operations to ensure that all
				prescription drugs in the facilities are maintained in accordance with the
				product labeling or in compliance with official compendium standards such as
				the United State Pharmacopeia-USP-NF;
(ii) Have storage areas designed to provide
				adequate lighting, ventilation, temperature, sanitation, humidity, space,
				equipment and security conditions;
(iii) Have a quarantine area for storage of
				prescription drugs that are outdated, damaged, deteriorated, misbranded or
				adulterated, counterfeit, or suspected of being counterfeit, otherwise unfit
				for distribution or wholesale distribution, or that are in immediate or sealed
				secondary containers that have been opened prior to receipt by the
				entity;
(iv) Be maintained in a
				clean and orderly condition;
(v) Be
				free from infestation of any kind;
(vi) Be a commercial location and not a
				personal dwelling or residence;
(vii) Provide for the secure and confidential
				storage of all information with restricted access and policies and procedures
				to protect the integrity and confidentiality of the information; and
(viii) Provide and maintain appropriate
				inventory controls in order to detect and document any theft, counterfeiting,
				or diversion of prescription drugs.